🇦🇺 Open-label, PK Cohort (Cohort B): ponsegromab low dose in Australia

Open-label, PK Cohort (Cohort B): ponsegromab low dose (open-label-pk-cohort-cohort-b-ponsegromab-low-dose) regulatory status in Australia.

Marketing authorisation

TGA

  • Status: approved

Open-label, PK Cohort (Cohort B): ponsegromab low dose in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Open-label, PK Cohort (Cohort B): ponsegromab low dose approved in Australia?

Yes. TGA has authorised it.

Who is the marketing authorisation holder for Open-label, PK Cohort (Cohort B): ponsegromab low dose in Australia?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.